MTAMTech CORPORATION
Update：2026/09/15
Industries
Main Industry
Biotechnology
Main Product/Service
1. Shortening New Drug Development Timelines and Saving R&D Expenses — MTAM/Screen/Trial (Matching Drugs to Cancer Patients): This service focuses on assisting CRO clients (pharmaceutical companies) by providing unique and innovative MTAM/HFA services, enhancing pharmacodynamic evaluation statistics and high-efficiency screening platforms, effectively shortening preclinical and clinical Phase I and Phase II timelines, saving approximately 80% of new drug development costs, while simultaneously tracking and analyzing preclinical trial data.
2. Screening Anticancer Drugs for Cancer Patients — MTAM/Select (Matching Patients to Cancer Drugs): This service focuses on rapid screening of anticancer drugs for cancer patient populations with an accuracy rate of over 90%, effectively enabling oncologists to promptly administer the most effective medication to each cancer patient, thereby improving treatment efficacy. Preventing the waste of national social security resources, reducing the financial burden of medical care on patients' families, and fighting for higher survival rates for cancer patients are precisely the original intentions behind the national promotion of personalized precision medicine.
(The content above was translated by AI.)
2. Screening Anticancer Drugs for Cancer Patients — MTAM/Select (Matching Patients to Cancer Drugs): This service focuses on rapid screening of anticancer drugs for cancer patient populations with an accuracy rate of over 90%, effectively enabling oncologists to promptly administer the most effective medication to each cancer patient, thereby improving treatment efficacy. Preventing the waste of national social security resources, reducing the financial burden of medical care on patients' families, and fighting for higher survival rates for cancer patients are precisely the original intentions behind the national promotion of personalized precision medicine.
(The content above was translated by AI.)
Founded Year
2016
Unified Business No.
43935711
Status
Active
Number of Employees
0
Total Paid-in
Capital
18,000,000 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Anti-cancer drug screening solution for application in personalized medicine and drug development
